Alliance for Pandemic Preparedness

June 5, 2020

Neutralizing Antibodies Responses to SARS-CoV-2 in COVID-19 Inpatients and Convalescent Patients

Category:

Topic:

  • Among 70 COVID-19 patients and patients who had recovered, all had detectable neutralizing anti-SARS-CoV-2 antibodies by 20 days of symptom onset. The study found that neutralizing antibodies were detected in COVID-19 patients even in the early stages of the disease. Older patients and those with more severe symptoms had higher levels of antibodies. 

Wang et al. (June 4, 2020). Neutralizing Antibodies Responses to SARS-CoV-2 in COVID-19 Inpatients and Convalescent Patients. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaa721